|8-K||2019-03-14||Earnings, Regulation FD, Exhibits|
|8-K||2019-03-07||Amend Bylaw, Exhibits|
|8-K||2019-01-14||Earnings, Regulation FD, Exhibits|
|8-K||2018-11-29||Earnings, Regulation FD, Exhibits|
|8-K||2018-10-15||Earnings, Regulation FD, Exhibits|
|8-K||2018-08-23||Earnings, Regulation FD, Exhibits|
|8-K||2018-07-16||Earnings, Regulation FD, Exhibits|
|PEB||Pebblebrook Hotel Trust||4,040|
|CCH||Collier Creek Holdings||561|
|HWCC||Houston Wire & Cable||101|
|JUVF||Juniata Valley Financial||0|
|Note 1: Business Description|
|Note 2: Significant Accounting Policies|
|Note 3: Inventories|
|Note 4: Stock Options|
|Note 5: Stock Based Compensation|
|Note 6: Earnings per Share|
|Note 7: Long Term Debt|
|Note 8: Revolving Line of Credit|
|Note 9: Subsequent Events|
|Item 2 - Management's Discussion and Analysis of Financial Condition and Results of Operations|
|Item 3 - Quantitative and Qualitative Disclosures About Market Risk|
|Item 4 - Controls and Procedures|
|Part II - Other Information|
|Balance Sheet||Income Statement||Cash Flow|
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
|☑||QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934|
For the quarterly period ended: November 30, 2018
|☐||TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934|
Commission File No.: 0-16035
(Exact name of registrant as specified in its charter)
|(State or other jurisdiction of||(IRS Employer|
|incorporation or organization)||Identification No.)|
2012 Rt. 9W, Milton, NY 12547
(Address of Principal Executive Offices) (Zip Code)
Issuer's telephone no., including area code: (845) 795-2020
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES ☑ NO ☐
Indicate by checkmark whether the registrant has submitted electronically and posted on its corporate website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (section 229.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). ☑ Yes ☐ No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act.
|Large Accelerated Filer ☐||Accelerated Filer ☐|
|Non-Accelerated Filer ☐||Smaller reporting company ☑|
|Emerging Growth company ☐|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). YES ☐ NO ☑
APPLICABLE ONLY TO CORPORATE ISSUERS:
Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date:
|Outstanding as of January 14, 2019|
|Common Stock, par value $.01 per share||15,194,774|
|Part I - Financial Information|
|Item 1 – Condensed Consolidated Financial Statements:||1 - 3|
|Condensed Consolidated Balance Sheets – November 30, 2018 (Unaudited) and February 28, 2018||1|
|Condensed Consolidated Statements of Operations and Comprehensive Income – Nine Months and Three Months Ended November 30, 2018 and 2017 (Unaudited)||2|
|Condensed Consolidated Statements of Stockholders Equity – Nine Months Ended November 30, 2018 and 2017 (Unaudited)||3|
|Condensed Consolidated Statements of Cash Flows – Nine Months Ended November 30, 2018 and 2017 (Unaudited)||4|
|Notes to Condensed Consolidated Financial Statements||5- 9|
|Item 2 - Management's Discussion and Analysis of Financial Condition and Results of Operations||10 –16|
|Item 3 – Quantitative and Qualitative Disclosures about Market Risk||17|
|Item 4 – Controls and Procedures||17|
|Part II - Other Information||18|
|Signatures and Certifications||19|
CONDENSED CONSOLIDATED BALANCE SHEETS
|Cash and cash equivalents||$||1,626,881||$||2,016,464|
|Accounts receivable (less allowance of $46,000)||1,163,316||774,778|
|Prepaid expenses and other current assets||289,797||139,406|
|Total current assets||8,914,229||8,690,631|
|Equipment, furnishings and building improvements, net||800,127||498,401|
|Intangible assets, net||125,813||136,576|
|Deferred tax asset||396,387||396,387|
|LIABILITIES AND STOCKHOLDERS’ EQUITY|
|Current maturities of long term debt||161,102||156,119|
|Income taxes payable||10,821||84,621|
|Total current liabilities||2,582,631||2,130,893|
|Deferred tax liability||385,384||385,384|
|Long term debt, less current maturities||748,994||870,532|
|Commitments and Contingencies||—||—|
|Common stock, $.01 par value; 25,000,000 shares authorized, 15,191,725 and 14,986,367 shares issued and outstanding, at November 30 and February 28, respectively||151,918||149,864|
|Additional paid-in capital||8,921,894||8,901,171|
|Accumulated other comprehensive income||—||101,605|
|Total stockholders’ equity||8,516,115||8,392,525|
|TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY||$||12,233,124||$||11,779,334|
See notes to unaudited condensed consolidated financial statements.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME
|Nine Months Ended|
|Three Months Ended|
|Cost of Goods Sold||4,761,919||4,162,819||1,858,970||1,517,414|
|Research and product development costs||978,733||941,497||324,969||324,324|
|Marketing and selling expenses||1,979,365||1,880,115||652,664||664,644|
|General and administrative costs||857,832||830,137||268,632||265,157|
|Total Operating Expenses||3,815,930||3,651,749||1,246,265||1,254,125|
|Interest and Dividend Income||104,686||58,298||33,164||22,087|
|Realized gain on sale of marketable securities||119,075||11,207||—||19,791|
|Net unrealized loss on marketable securities||(189,016||)||—||(59,359||)||—|
|Income Before Income Taxes||128,440||357,399||22,825||234,810|
|Income Tax Expense||27,627||92,443||2,566||40,368|
|Other Comprehensive Income|
|Net unrealized gain on marketable securities||—||111,137||—||51,499|
|Basic Earnings Per Share||$||0.01||$||0.02||$||0.00||$||0.01|
|Diluted Earnings Per Share||$||0.01||$||0.02||$||0.00||$||0.01|
|Weighted Average Shares - Basic||15,078,933||14,964,048||15,164,440||14,969,933|
|Weighted Average Shares - Diluted||15,284,071||15,073,576||15,386,094||15,113,389|
See notes to unaudited condensed consolidated financial statements.
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
NINE MONTHS ENDED NOVEMBER 30, 2018 AND 2017
Paid – In
|Balance – February 28, 2017||14,961,076||$||149,611||$||8,859,486||$||42,250||$||(1,128,322||)||$||7,923,025|
|Exercise of stock options||15,568||156||55||211|
|Stock based compensation expense||31,536||31,536|
|Unrealized gain on marketable securities||111,137||111,137|
|Balance – November 30, 2017 (unaudited)||14,976,644||$||149,767||$||8,891,077||$||153,387||$||(863,366||)||$||8,330,865|
|Balance – February 28, 2018||14,986,367||$||149,864||$||8,901,171||$||101,605||$||(760,115||)||$||8,392,525|
|Reclassification of unrealized gain on marketable securities upon adoption of ASU 2016-01||(101,605||)||101,605||—|
|Exercise of stock options||205,358||2,054||(2,054||)||—|
|Stock based compensation expense||22,777||22,777|
|Balance – November 30, 2018 (unaudited)||15,191,725||$||151,918||$||8,921,894||$||—||$||(557,697||)||$||8,516,115|
See notes to unaudited condensed consolidated financial statements.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
|Nine Months Ended|
|CASH FLOWS FROM OPERATING ACTIVITIES:|
|Adjustments to reconcile net income to net cash provided by operating activities:|
|Depreciation and amortization||256,519||279,848|
|Stock based compensation expense||22,777||31,536|
|Unrealized loss on marketable securities||189,016||—|
|Decrease (Increase) in:|
|Prepaid expenses and other current assets||(150,391||)||20,841|
|(Decrease) Increase in:|
|Accounts payable and accrued expenses||(99,748||)||186,659|
|Income taxes payable||(73,800||)||37,555|
|Net Cash Provided by Operating Activities||88,149||1,404,967|
|CASH FLOWS FROM INVESTING ACTIVITIES:|
|Purchase of equipment and furnishings||(486,711||)||(157,727||)|
|Sale (purchase) of marketable securities||125,534||(1,994,175||)|
|Net Cash Used in Investing Activities||(361,177||)||(2,151,902||)|
|CASH FLOWS FROM FINANCING ACTIVITIES:|
|Proceeds from exercise of stock options||—||210|
|Repayment of long term debt||(116,555||)||(111,777||)|
|Net Cash Used In Financing Activities||(116,555||)||(111,567||)|
|NET DECREASE IN CASH AND CASH EQUIVALENTS||(389,583||)||(858,502||)|
|CASH AND CASH EQUIVALENTS|
|Beginning of period||2,016,464||2,557,223|
|End of period||$||1,626,881||$||1,698,721|
|SUPPLEMENTAL CASH FLOW DISCLOSURE:|
|Income Taxes Paid||$||101,426||$||58,969|
See notes to unaudited condensed consolidated financial statements.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NINE MONTHS ENDED November 30, 2018 and 2017
NOTE 1: BUSINESS DESCRIPTION
Sono-Tek Corporation (the “Company”, “Sono-Tek”, “We” or “Our”) is the world leader in the design and manufacture of ultrasonic coating systems for applying precise, thin film coatings to protect, strengthen or smooth surfaces on parts and components for the microelectronics/electronics, alternative energy, medical, industrial and emerging research & development/other markets. We design and manufacture custom-engineered ultrasonic coating systems and also provide patented nozzles and generators for manufacturers’ equipment.
The accompanying unaudited Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information. Accordingly, the Consolidated Financial Statements do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of the Company’s management, all adjustments considered necessary for a fair presentation (consisting of normal recurring adjustments) have been included. The results for the interim periods are not necessarily indicative of what the results will be for the full fiscal year. The accompanying Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements as of and for the fiscal year ended February 28, 2018 (“fiscal year 2018”) contained in the Company’s 2018 Annual Report on Form 10-K filed with the SEC. The Company’s current fiscal year ends on February 28, 2019 (“fiscal 2019”).
NOTE 2: SIGNIFICANT ACCOUNTING POLICIES
Marketable Securities - The Company adopted ASU 2016-01, “Financial Instruments – Overall: Recognition and Measurement of Financial Assets and Financial Liabilities.” ASU 2016-01 requires equity investments (except those accounted for under the equity method of accounting, or those that result in consolidation of the investee) to be measured at fair value with changes in fair value recognized in net income, requires public business entities to use the exit price notion when measuring the fair value of financial instruments for disclosure purposes, requires separate presentation of financial assets and financial liabilities by measurement category and form of financial asset, and eliminates the requirement for public business entities to disclose the method(s) and significant assumptions used to estimate the fair value that is required to be disclosed for financial instruments measured at amortized cost. The Company has evaluated the potential impact this standard may have on the condensed consolidated financial statements and the fair value allowance of the securities from the prior year has been reclassified to Retained Earnings from Other Accumulated Comprehensive Income. The unrealized loss on the marketable securities during the three and nine months ended November 30, 2018 has been disclosed a separate line item on the Income Statement.
Cash and Cash Equivalents - Cash and cash equivalents consist of money market mutual funds, short term commercial paper and short-term certificates of deposit with original maturities of 90 days or less.
Consolidation - The accompanying condensed consolidated financial statements of the Company, include the accounts of the Company and its wholly owned subsidiary, Sono-Tek Industrial Park, LLC (“SIP”). SIP operates as a real estate holding company for the Company’s real estate operations.
Earnings Per Share - Basic earnings per share (“EPS”) is computed by dividing net income by the weighted-average number of common shares outstanding for the period. Diluted EPS reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock.
Equipment, Furnishings and Leasehold Improvements – Equipment, furnishings and leasehold improvements are stated at cost. Depreciation of equipment and furnishings is computed by use of the straight-line method based on the estimated useful lives of the assets, which range from three to five years.
Fair Value of Financial Instruments - The Company follows the guidance in the “Fair Value Measurements and Disclosure Topic” of the Accounting Standards Codification for assets and liabilities measured at fair value on a recurring basis. This guidance establishes a common definition for fair value to be applied to existing generally accepted accounting principles that require the use of fair value measurements, establishes a framework for measuring fair value and expands disclosure about such fair value measurements. The guidance defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Additionally, the guidance requires the use of valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs. These inputs are prioritized below:
Level 1: Quoted prices in active markets.
Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.
Level 3: Unobservable inputs for which there is little or no market data, which require the use of the reporting entity’s own assumptions.
The fair values of financial assets of the Company were determined using the following categories at November 30, 2018 and February 28, 2018, respectively:
|Quoted Prices in Active Markets|
Marketable Securities include mutual funds of $4,091,350 and $4,405,900 that are considered to be highly liquid and easily tradeable as of November 30, 2018, and February 28, 2018, respectively. These securities are valued using inputs observable in active markets for identical securities and are therefore classified as Level 1 within the Company’s fair value hierarchy. The Company’s marketable securities are considered to be available-for-sale investments as defined under ASC 320 “Investments – Debt and Equity Securities.”
Income Taxes - The Company accounts for income taxes under the asset and liability method. Under this method, deferred income taxes are recognized for the tax consequences of "temporary differences" by applying enacted statutory tax rates applicable to future years to differences between the financial statement carrying amounts and the tax basis of existing assets and liabilities. If it is more likely than not that some portion or all of a deferred tax asset will not be realized, a valuation allowance is recognized.
Intangible Assets - Include costs of patent applications which are deferred and charged to operations over seventeen years for domestic patents and twelve years for foreign patents. The accumulated amortization of patents is $157,678 and $149,654 at November 30, 2018 and February 28, 2018, respectively. Annual amortization expense of such intangible assets is expected to be approximately $11,000 per year for the next five years.
Interim Reporting - The attached summary condensed consolidated financial information does not include all disclosures required to be included in a complete set of financial statements prepared in conformity with accounting principles generally accepted in the United States of America. Such disclosures were included with the financial statements of the Company at February 28, 2018, and included in its report on Form 10-K. Such statements should be read in conjunction with the data herein.
The financial information reflects all adjustments, normal and recurring, which, in the opinion of management, are necessary for a fair presentation of the results for the interim periods presented. The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The results for such interim periods are not necessarily indicative of the results to be expected for the year.
Inventories - Inventories are stated at the lower of cost or market. Cost is determined using the first-in, first-out (FIFO) method for raw materials, subassemblies and work-in-progress and the specific identification method for finished goods.
Land and Buildings – Land and buildings are stated at cost. Buildings are being depreciated by use of the straight-line method based on an estimated useful life of forty years.
Long-Lived Assets - The Company periodically evaluates the carrying value of long-lived assets, including intangible assets, when events and circumstances warrant such a review. The carrying value of a long-lived asset is considered impaired when the anticipated undiscounted cash flow from such asset is separately identifiable and is less than its carrying value. In that event, a loss is recognized based on the amount by which the carrying value exceeds the fair market value of the long-lived asset. Fair market value is determined primarily using the anticipated cash flows discounted at a rate commensurate with the risk involved.
Management Estimates - The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
New Accounting Pronouncements- In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09, “Revenue from Contracts with Customers” (Topic 606), to clarify the principles of recognizing revenue and create common revenue recognition guidance between U.S. GAAP and International Financial Reporting Standards. Under ASU 2014-09, revenue is recognized when a customer obtains control of promised goods or services and is recognized at an amount that reflects the consideration expected to be received in exchange for such goods or services. In addition, ASU 2014-09 requires disclosure of the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. The ASU is effective for fiscal years beginning after December 15, 2017.
The new revenue standard is principle based and interpretation of those principles may vary from company to company based on their unique circumstances. It is possible that interpretation, industry practice, and guidance may evolve as companies and the accounting profession work to implement this new standard. The implementation of the standard did not have a material impact on the financial statements.
In January 2016, the FASB issued ASU 2016-01, “Financial Instruments – Overall: Recognition and Measurement of Financial Assets and Financial Liabilities.” ASU 2016-01 requires equity investments (except those accounted for under the equity method of accounting, or those that result in consolidation of the investee) to be measured at fair value with changes in fair value recognized in net income, requires public business entities to use the exit price notion when measuring the fair value of financial instruments for disclosure purposes, requires separate presentation of financial assets and financial liabilities by measurement category and form of financial asset, and eliminates the requirement for public business entities to disclose the method(s) and significant assumptions used to estimate the fair value that is required to be disclosed for financial instruments measured at amortized cost. ASU 2016-01 is effective for all entities for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. The Company has evaluated the potential impact this standard may have on the condensed consolidated financial statements, the fair value of the securities from the prior year has been reclassified to Retained Earnings from Other Accumulated Comprehensive Income. The unrealized loss on the marketable securities during the three and nine months ended November 30, 2018 has been recorded in Other Income on the Income Statement.
In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), to increase transparency and comparability among organizations by recognizing a right-of-use asset and a lease liability on the balance sheet for all leases with terms longer than 12 months. Leases will be classified as either operating or financing, with such classification affecting the pattern of expense recognition in the income statement. ASU 2016-02 is effective for fiscal years and interim periods within those years beginning after December 15, 2018, and early adoption is permitted. The Company is currently evaluating the impact of adopting ASU 2016-02.
In February 2018, the FASB issued ASU 2018-02, Income Statement - Reporting Comprehensive Income (Topic 220), “Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income”. ASU 2018-02 was issued to allow the reclassification from accumulated other comprehensive income to retained earnings for the stranded tax effect resulting from the Tax Cuts and Jobs Act enacted on December 22, 2017. The Tax Cuts and Jobs Act, among other things, reduced the corporate tax rate from 35% to 21%, which required the re-evaluation of any deferred tax assets and liabilities at the lowered tax rate which potentially could leave a disproportionate tax effect in accumulated other comprehensive income. ASU 2018-02 allows for the election to reclassify these stranded tax effects to retained earnings. ASU 2018-02 is effective for all entities for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption is permitted, including adoption in any interim period for public business entities for reporting periods for which financials statements have not yet been issued. The Company is currently evaluating the impact of adopting ASU 2018-02.
Other than ASU No. 2014-09, ASU 2016-01, ASU 2016-02 and ASU 2018-02 discussed above, all new accounting pronouncements issued but not yet effective have been deemed to be not applicable to the Company. Hence, the adoption of these new accounting pronouncements, once effective, is not expected to have an impact on the Company.
Reclassifications – Where appropriate, certain reclassifications have been made to the prior period to conform to the presentations of the current period.
NOTE 3: INVENTORIES
Inventories consist of the following:
|November 30,||February 28,|
|Raw materials and subassemblies||$||872,430||$||673,969|
|Work in process||472,432||489,082|
NOTE 4: STOCK OPTIONS
Stock Options – Under the 2013 Stock Incentive Plan ("2013 Plan"), options can be granted to officers, directors, consultants and employees of the Company and its subsidiaries to purchase up to 2,500,000 shares of the Company's common stock. Under the 2013 Plan options expire ten years after the date of grant. As of November 30, 2018, there were 475,500 options outstanding under the 2013 Plan.
Under the 2003 Stock Incentive Plan, as amended ("2003 Plan"), until May 2013, options were available to be granted to officers, directors, consultants and employees of the Company and its subsidiaries to purchase up to 1,500,000 shares of the Company's common stock. As of November 30, 2018, there were 100,500 options outstanding under the 2003 Plan, under which no additional options may be granted.
During the nine months ended November 30, 2018, 361,100 options were exercised on a cashless basis into 205,358 shares of common stock.
NOTE 5: STOCK BASED COMPENSATION
The Company adopted ASC 718, “Share Based Payments.” which requires companies to expense the value of employee stock options and similar awards.
The weighted-average fair value of options are estimated on the date of grant using the Black-Scholes options-pricing model. For the nine months ended November 30, 2018, 12,500 options were issued to employees with an exercise price of $2.55 and 20,000 options were issued to a member of the board of directors with an exercise price of $3.00. The options vest annually over three years and expire in ten years. The options had a weighted average grant date fair value of $0.97 per share, determined using the Black-Scholes options-pricing model with the following assumptions:
|Nine Months Ended November 30,|
|Expected life||8 years||2-8 years|
|Risk free interest rate||2.68% - 2.98%||1.79% - 2.01%|
|Expected volatility||24.82% - 28.24%||12.65% - 18.06%|
|Expected dividend yield||0%||0%|
During the nine months ended November 30, 2017, the Company granted options to acquire 110,000 shares to an officer, at an exercise price of $1.06 and options for 7,500 shares at an exercise price of $1.15 to employees of the Company.
In computing the impact, the fair value of each option is estimated on the date of grant based on the Black-Scholes options-pricing model utilizing certain assumptions for a risk free interest rate; volatility; and expected remaining lives of the awards. The assumptions used in calculating the fair value of share-based payment awards represent management’s best estimates, but these estimates involve inherent uncertainties and the application of management judgment. As a result, if factors change and the Company uses different assumptions, the Company’s stock-based compensation expense could be materially different in the future. In addition, the Company is required to estimate the expected forfeiture rate and only recognize expense for those shares expected to vest. In estimating the Company’s forfeiture rate, the Company analyzed its historical forfeiture rate, the remaining lives of unvested options, and the number of vested options as a percentage of total options outstanding. If the Company’s actual forfeiture rate is materially different from its estimate, or if the Company reevaluates the forfeiture rate in the future, the stock-based compensation expense could be significantly different from what the Company has recorded in the current period.
For the three and nine months ended November 30, 2018 and 2017, net income and earnings per share reflect the actual deduction for stock-based compensation expense. The impact of applying ASC 718 approximated $7,000 and $11,000 in additional compensation expense during the three months ended November 30, 2018 and 2017, respectively. The impact of applying ASC 718 approximated $23,000 and $32,000 in additional compensation expense during the nine months ended November 30, 2018 and 2017, respectively. Such amounts are included in general and administrative expenses on the statement of operations. The expense for stock-based compensation is a non-cash expense item.
NOTE 6: EARNINGS PER SHARE
The denominators for the calculation of diluted earnings per share at November 30, 2018 and 2017 are calculated as follows:
|Nine Months Ended||Three Months Ended|
|November 30,||November 30,|
|Numerator for basic and diluted earnings per share||$||100,813||$||264,956||$||20,259||$||194,442|
|Denominator for basic earnings per share – weighted average||15,078,933||14,964,048||15,164,440||14,969,933|
|Effects of dilutive securities|
|Stock options for employees, directors and outside consultants||205,138||109,528||221,654||143,456|
|Denominator for diluted earnings per share||15,284,071||15,073,576||15,386,094||15,113,389|
|Basic earnings per share||$||0.01||$||0.02||$||0.00||$||0.01|
|Diluted earnings per share||$||0.01||$||0.02||$||0.00||$||0.01|
NOTE 7: LONG TERM DEBT
Long-term debt consists of the following:
|November 30,||February 28,|
|Note payable, bank, collateralized by land and buildings, payable in monthly installments of principal and interest of $16,358 through January 2024 with an interest rate of 4.15% and a 10-year term.||$||910,096||$||1,026,651|
|Total long term debt||910,096||1,026,651|
|Due within one year||161,102||156,119|
|Due after one year||$||748,994||$||870,532|
NOTE 8: REVOLVING LINE OF CREDIT
The Company has a $750,000 revolving line of credit at prime which was 5.25% at November 30, 2018. The loan is collateralized by all of the assets of the Company, except for the land and buildings. The line of credit is payable on demand and must be retired for a 30-day period, once annually. If the Company fails to perform the 30-day annual pay down or if the bank elects to terminate the credit line, the bank may, at its option, convert the outstanding balance to a 36-month term note with payments including interest in 36 equal installments. As of November 30, 2018, $659,078 of the Company’s credit line was being utilized to collateralize a letter of credit issued to a customer that has remitted a cash deposit to the Company on an order and the unused portion of the credit line was $90,922. The letter of credit expires in 2020. As of February 28, 2018, the Company’s outstanding balance was $0, and the unused credit line was $750,000.
NOTE 9: SUBSEQUENT EVENTS
The Company has evaluated subsequent events for disclosure purposes.
ITEM 2 – Management’s Discussion and Analysis of Financial Condition and Results of Operations
We discuss expectations regarding our future performance, such as our business outlook, in our annual and quarterly reports, news releases, and other written and oral statements. These “forward-looking statements” are based on currently available competitive, financial and economic data and our operating plans. They are inherently uncertain, and investors must recognize that events could turn out to be significantly different from our expectations and could cause actual results to differ materially. These factors include, among other considerations, general economic and business conditions; political, regulatory, tax, competitive and technological developments affecting our operations or the demand for our products, including the imposition of tariffs; timely development and market acceptance of new products and continued customer validation of our coating technologies; adequacy of financing; capacity additions, the ability to enforce patents; maintenance of operating leverage; maintenance of increased order backlog; consummation of order proposals; completion of large orders on schedule and on budget; continued sales growth in the medical and alternative energy markets; successful transition from primarily selling ultrasonic nozzles and components to a more complex business providing complete machine solutions and higher value subsystems; and realization of quarterly and annual revenues within the forecasted range.
We undertake no obligation to update any forward-looking statement.
Founded in 1975, Sono-Tek Corporation designs and manufactures ultrasonic coating systems that apply precise, thin film coatings to a multitude of products for the microelectronics/electronics, alternative energy, medical and industrial markets, including specialized glass applications in construction and automotive. We also sell our products to emerging research and development and other markets. We have invested significant resources to enhance our market diversity. Founded on our core ultrasonic coating technology, we have increased our portfolio of products, the industries we serve, and the countries in which we sell our products.
Our ultrasonic nozzle systems use high frequency, ultrasonic vibrations that atomize liquids into minute drops that can be applied to surfaces at low velocity providing thin layers of protective materials over a surface such as glass. Our solutions are environmentally-friendly, efficient and highly reliable. They enable dramatic reductions in overspray, savings in raw material, water and energy usage and provide improved process repeatability, transfer efficiency, high uniformity and reduced emissions.
We believe product superiority is imperative in all that we produce and that it is developed through the extensive experience we have in the coatings industry, our proprietary manufacturing know-how and skills and our unique work force we have built over the years. Our growth strategy is focused on leveraging our innovative technologies, proprietary know-how, unique talent and experience, and global reach to further develop thin film coating technologies that enable better outcomes for our customers’ products and processes.
We are a global business with approximately 62% of our sales generated from outside the United States in the first nine months of fiscal 2019. Our direct sales team and our distributor and sales representative network are located in North America, Latin America, Europe and Asia. Over the last few years, we have expanded our sales capabilities by increasing the size of our direct sales force and adding new distributors and sales representatives (“reps”). Of note, we have developed demonstration labs in Asia and at our facility in New York that are used to train our distributors and reps. These labs are also very valuable for demonstrating to prospective customers the capabilities of our equipment and enable us to develop custom solutions to meet their needs.
Over the last few years, we have shifted our business from primarily selling our ultrasonic nozzles and components to a more complex business providing complete machine solutions and higher value subsystems to original equipment manufacturers (“OEMs”). The range for our average unit selling price has broadened as a result to $50 thousand per unit to over $240 thousand per unit. As a result, we can experience wide variations in both order flow and shipments from quarter to quarter.
Third Quarter Fiscal 2019 Highlights (compared with the third quarter of fiscal 2018 unless otherwise noted) We refer to the three-month periods ended November 30, 2018 and 2017 as the third quarter of fiscal 2019 and fiscal 2018, respectively.
|•||Net sales were $3,155,000, up 7% or $195,000, driven by increased sales of highly customized, more complex systems to the Alternative Energy markets. These machines are primarily our multi-axis machines that also require advanced motion control systems developed by outsourced providers.|
|•||Gross profit margin was 41.1% compared with 48.7%. Lower gross profit margin reflects the change in mix toward complex coating machines with increased outsourced content combined with an aggressive pricing strategy to establish a leading market position in the China fuel cell market.|
|•||Strong cost discipline was more than offset by the decline in gross profit margin resulting in lower operating income of $50,000 compared with $188,000.|
|•||A decrease in net Other Income and Expense contributed further to a decrease in net income. Net Other Expense was $27,000 for the 2019 period (including unrealized loss on marketable securities of $59,000), compared with net Other Income of $47,000 for the 2018 period. As a result of this and the decline in gross profit, net income declined to $20,000 from $194,000.|
|•||Backlog more than doubled and reached a record level of $3,040,000. This compares with a backlog of $1,238,000 on February 28, 2018, and $1,448,000 at the end of the second quarter of fiscal 2019, which ended August 31, 2018. Included in the recent backlog total was the Company’s highest value single ultrasonic coating machine order to date, valued at approximately $1,670,000. This machine is scheduled to be delivered by the end of fiscal 2020, which concludes on February 29, 2020. Orders can be highly variable from quarter-to-quarter resulting in large fluctuations in backlog, as product shipments are more systematically managed for both customer timing requirements and staffing management. Excluding the large machine order, the rest of the backlog is expected to ship within one year.|
Nine Month Fiscal 2019 Highlights (compared with the first nine months of fiscal 2018 unless otherwise noted) We refer to the nine-month periods ended November 30, 2018 and 2017 as the first nine months of fiscal 2019 and fiscal 2018, respectively.
|•||Net sales were $8,674,000, up 7% or $560,000, driven primarily by the Medical and Alternative Energy markets as the effectiveness of our efforts to provide application engineering expertise and more complete subsystems increased customer demand for custom-designed, higher value complex machines as well as higher demand from original equipment manufacturers for application-focused subsystems.|
|•||Gross profit margin was 45.1% compared with 48.7%, which reflects changes in product mix toward more complex machines requiring more outsourced hardware content.|
|•||Operating income declined to $96,000 compared with $299,000. Growth in revenue was offset by a decline in gross profit margin as discussed above, as well as continued investments in research & development, sales & marketing and higher professional expenses.|
|•||A decrease in net Other Income and Expense contributed further to a decrease in net income. Net Other Income was $32,000 for the 2019 period (including unrealized loss on marketable securities of $189,000), compared with net Other Income of $58,000 for the 2018 period. As a result of this and the decline in gross profit, net income was $101,000 compared with $265,000.|
|•||Cash and marketable securities declined $704,000 during the nine months ended November 30, 2018. The principal reasons for this decline were an increase in accounts receivable of $389,000 and an increase in inventories of $389,000. Higher accounts receivable was due to timing, as customer scheduling requests resulted in approximately 53% of the quarter’s shipments to occur in the month of November. Inventory increased to support orders in backlog.|
RESULTS OF OPERATIONS
|Three Months Ended |
|Change||Nine Months Ended |
|Integrated Coating Systems||286,000||426,000||(140,000||)||(33%)||917,000||1,676,000||(759,000||)||(45%)|
|Multi-Axis Coating Systems||1,681,000||1,251,000||430,000||34%||3,813,000||3,016,000||797,000||26%|
Sales growth was driven by more complex, highly engineered and higher value multi-axis coating machines primarily for the Alternative Energy markets in the third quarter, and for the Medical and Alternative Energy markets in the first nine months of fiscal 2019. This equipment can range from $100 thousand to over $240 thousand per unit and is typically ordered in one or two unit volumes. Our ability to provide subsystems and components including our custom-designed Align system, which OEMs include in their equipment, drove higher sales of this product category. Growth in these product categories more than offset the decline in integrated coating systems, which primarily are for more mature applications in the Medical market and can be highly variable in order volume.
|Three Months Ended||Nine Months Ended|
|November 30,||Change||November 30,||Change|
|Emerging R&D and Other||137,000||254,000||(117,000||)||(46%)||238,000||438,000||(200,000||)||(46%)|
Use of our development laboratory by customers has recently reached record levels, which we believe demonstrates the success of our strategy to provide excellent application engineering expertise as well as paid coating services to prospects and customers to validate the capabilities of our coating technologies for their uses. These service-based customers are guided by our applications engineering team, to develop successful coating processes for their unique needs. Upon achieving coating results that meet the application requirements, the customer's next step is typically to purchase the defined coating solution. We believe a high level of prospects and customers that use our lab services to develop their products results in sales. In the first nine months of fiscal 2019, the Medical industry has been especially active in our labs and has resulted in growth in sales to this market.
As expected, sales were stronger to the Alternative Energy market in the third quarter as the Company shipped three ultrasonic coating solutions to new fuel cell customers in China. We expect that this market will see growth for the remainder of the fiscal year. Over the long term, demand from this market is poised for substantial growth as the industry continues to scale up from R&D prototype production to low rate production.
Third quarter declines in sales to the Medical and Emerging R&D/Other markets are mostly the result of variations in demand and applications from period to period.
|Three Months Ended |
|Change||Nine Months Ended |
|U.S. & Canada||$||1,211,000||$||1,181,000||30,000||3%||$||3,283,000||$||3,470,000||(187,000||)||(5%)|
|Asia Pacific (APAC)||1,368,000||714,000||654,000||92%||2,744,000||1,786,000||958,000||54%|
|Europe, Middle East, Asia (EMEA)||440,000||813,000||(373,000||)||(46%)||1,990,000||2,047,000||(57,000||)||(3%)|
In both the third quarter and first nine months of fiscal 2019, approximately 62% of sales originated outside of the United States and Canada compared with 60% in the prior-year third quarter and 57% in the first nine months of fiscal 2018.
|Three Months Ended |
|Change||Nine Months Ended |
|Cost of Goods Sold||1,859,000||1,518,000||341,000||22%||4,762,000||4,163,000||599,000||14%|
|Gross Profit %||41.1%||48.7%||45.1%||48.7%|
The decrease in gross margin in the third quarter was primarily a result of pricing strategy to establish a leading foothold in the fuel cell market in China. In addition, margin was negatively impacted by changes in product mix toward more complex machines requiring more outsourced hardware content.
|Three Months Ended|
|Change||Nine Months Ended|
|Research and product development||$||325,000||$||324,000||1,000||—||$||979,000||$||941,000||38,000||4%|
|Marketing and selling||653,000||665,000||(12,000||)||(2%)||1,979,000||1,880,000||99,000||5%|
|General and administrative||$||269,000||$||265,000||4,000||2%||$||858,000||$||830,000||28,000||3%|
Research and Product Development:
For the third quarter of fiscal 2019, research and product development costs were relatively consistent with the prior-year period.
For the first nine months of fiscal 2019, research and product development costs increased $38,000 as a result of higher salary expense and related health insurance costs from the addition of personnel. These expenses were partially offset by decreases in engineering supplies and materials.
Marketing and Selling:
Reduced marketing and selling costs for the third quarter of fiscal 2019 were related to decreases in international commission expense and trade show expense. These decreases were partially offset by increases in salaries, health insurance premiums and travel expense.
Higher marketing and selling costs for the first nine months of fiscal 2019 were due to increased salaries, health insurance premiums, travel expenses and international distributor training. These increases were partially offset by decreases in international commission expense and trade show expense.
General and Administrative:
General and administrative costs were up modestly in the third quarter of fiscal 2019 and reflect increases in professional fees, health insurance and other corporate expenses. These increases were partially offset by lower stock-based compensation expense and salary expense.
General and administrative costs were up 3% during first nine months of fiscal 2019 as health insurance premiums, other corporate expenses and professional fees increased. Higher professional services costs include the services of an investor relations firm, which began in the second quarter of the fiscal year. These increases were partially offset by decreases in salary expense, stock-based compensation expense and depreciation expense.
Operating income decreased to $50,000 in the third quarter of fiscal 2019, compared with $188,000, reflecting the 10% decrease in gross profit that was partially offset by 1% lower operating expenses. Operating margin for the third quarter of fiscal 2019 decreased to 1.6% from 6.4%. For the first nine months of fiscal 2019, operating income was $96,000, or 1.1% of sales, compared with $299,000, or 3.7% of sales.
We continue to invest in research and product development, as well as marketing and selling activities, in order to expand our future market opportunities. We expect with continued growth, we will begin to demonstrate operating leverage and improved margins.
Interest expense was $10,000 in the third fiscal quarter of 2019 compared with $11,000 for the prior-year period. For the first nine months of fiscal 2019, interest expense was $31,000 compared with $35,000. Interest expense is directly related to the Company's mortgage on the industrial park.
Interest and Dividend Income:
In the third quarter of fiscal 2019, interest and dividend income increased to $33,000 from $22,000, and in the first nine months of fiscal 2019 increased to $105,000 from $58,000. Our present investment policy is to invest excess cash in highly liquid, lower risk fixed income mutual funds. At November 30, 2018, the majority of our holdings are rated at or above investment grade.
Net unrealized loss on marketable securities:
The Company adopted ASU 2016-01, “Financial Instruments – Overall: Recognition and Measurement of Financial Assets and Financial Liabilities” in the first quarter of fiscal 2019. ASU 2016-01 requires the Company to measure its equity investments at fair value and changes in fair value are to be recognized in net income. Further information is available in NOTE 2: SIGNIFICANT ACCOUNTING POLICIES in our financial statements.
In the third quarter of fiscal 2019, net income and earnings per share reflect the $59,000 unrealized loss on our marketable securities.
In the third quarter of fiscal 2018, changes in the fair value of our marketable securities were not recognized in net income, they were recorded as a component of Other Comprehensive Income. In the third quarter of fiscal 2018, the Company reported $51,000 as an unrealized gain on marketable securities in Other Comprehensive Income.
In the first nine months of fiscal 2019, net income and earnings per share reflect the $189,000 unrealized loss on our marketable securities.
In the first nine months of fiscal 2018, changes in the fair value of our marketable securities were not recognized in net income, they were recorded as a component of Other Comprehensive Income. In the first nine months of fiscal 2018, the company reported $111,000 as an unrealized gain on marketable securities in Other Comprehensive Income.
Included in other income is the net revenue related to the rental of the Company’s real estate.
For the third quarter of fiscal 2019, the Company’s rental revenue was $22,000, expenses were $13,000 and net revenue was $9,000. This compares with the third quarter of fiscal 2018 when rental revenue was $23,000, expenses were $13,000 and net revenue was $10,000.
For the first nine months of fiscal 2019, the Company’s rental revenue was $63,000, expenses were $43,000 and net revenue was $20,000. This compares with the first nine months of fiscal 2018 when rental revenue was $55,000, expenses were $38,000 and net revenue was $17,000.
Income Tax Expense:
We recorded income tax expense of $3,000 for the third quarter of fiscal 2019 compared with $40,000 for the third quarter of fiscal 2018.
We recorded income tax expense of $28,000 for the first nine months of fiscal 2019 compared with $92,000 for the first nine months of fiscal 2018.
Net income decreased to $20,000 for the third quarter of fiscal 2019 compared with $194,000 for the prior-year period. The decrease was due to $138,000 in lower operating profit, $79,000 net loss on marketable securities ($20,000 decline in realized gain plus $59,000 unrealized loss) and $8,000 decrease in other income, partially offset by $13,000 net increase in interest and dividend and interest expense and lower income tax expense of $38,000.
Net income decreased to $101,000 for the first nine months of fiscal 2019 compared with $265,000 for the prior-year period. The decrease reflects $203,000 in lower operating profit and $81,000 net loss on marketable securities ($108,000 increase in realized gain offset by $189,000 unrealized loss), partially offset by $51,000 net increase in interest and dividend income and interest expense, $4,000 increase in other income and lower income tax expense of $65,000.
LIQUIDITY AND CAPITAL RESOURCES
Working Capital – Our working capital decreased $228,000 to $6,332,000 at November 30, 2018 from $6,560,000 at February 28, 2018. The decrease in working capital was mostly a result of a reduction in cash used for investments in equipment and repayment of long-term debt offset by the current period's net income and noncash charges.
The Company aggregates cash and cash equivalents and marketable securities in managing its balance sheet and liquidity. For purposes of the following analysis, the total is referred to as “Cash.” At November 30, 2018 and February 28, 2018, our working capital included:
|Cash and cash equivalents||$||1,627,000||$||2,016,000||($||389,000||)|
The following table summarizes the accounts and the major reasons for the $704,000 decrease in “Cash”:
|Impact on Cash||Reason|
|Accounts receivable increase||$||(389,000)||53% of current quarters shipments occurred in November 2018.|
|Inventories increase||(437,000)||Required to support backlog.|
|Equipment purchases||(487,000)||Equipment upgrade for productivity.|
|Customer deposits increase||620,000||Received for new orders.|
|Other - net||(11,000)||Timing of disbursements.|
|Net decrease in cash||$||(704,000)|
Stockholders’ Equity – Stockholder’s Equity increased $123,000 to $8,516,000 at November 30, 2018, from $8,393,000 at February 28, 2018. The increase was a result of the current period’s net income of $101,000 and stock-based compensation expense of $23,000.
Operating Activities – We generated $88,000 of cash in our operating activities in the first nine months of fiscal 2019 compared with $1,405,000 in the first nine months of fiscal 2018. The reduction in cash generated by operating activities was mostly the result of lower net income and higher inventories, prepaid expenses and accounts receivable.
Investing Activities – For the first nine months of fiscal 2019, cash used by investing activities was $361,000 compared with using $2,152,000 of cash for the first nine months of fiscal 2018. For the first nine months of fiscal year 2019, we used $487,000 for the purchase or manufacture of equipment, furnishings and leasehold improvements, which included $337,000 of cash to upgrade our CNC machinery. This compares with $158,000 for the purchase of equipment and furnishings for the first nine months of fiscal year 2018. The Company expects that capital expenditures for the remainder of fiscal 2019 to be nominal for a total of approximately $0.5 million.
For the first nine months of 2019 our marketable securities provided $126,000 and we used $1,994,000 in the first nine months of 2018.
Financing Activities – In the first nine months of fiscal years 2019 and 2018, we used $117,000 and $112,000 in cash, respectively, for the principal payments on our mortgage.
Net (Decrease) in Cash and Cash Equivalents – In the first nine months of fiscal 2019 our cash balance decreased by $390,000 compared with a decrease of $858,000 in the first nine months of fiscal 2018. In the first nine months of fiscal 2019, we generated $88,000 in our operations. In addition, we used $487,000 for the purchase or manufacture of equipment, furnishings and leasehold improvements, received $126,000 from the sale of marketable securities and used $117,000 for the repayment of our notes payable.
CRITICAL ACCOUNTING POLICIES
The discussion and analysis of the Company’s financial condition and results of operations are based upon the consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these financial statements requires the Company to make estimates and judgments that affect the reported amount of assets and liabilities, revenues and expenses, and related disclosure on contingent assets and liabilities at the date of the financial statements. Actual results may differ from these estimates under different assumptions and conditions.
Critical accounting policies are defined as those that are reflective of significant judgments and uncertainties, and may potentially result in materially different results under different assumptions and conditions. The Company believes that critical accounting policies are limited to those described below. For a detailed discussion on the application of these and other accounting policies see Note 2 to the Company’s consolidated financial statements included in Form 10-K for the year ended February 28, 2018.
Accounting for Income Taxes
As part of the process of preparing the Company’s condensed consolidated financial statements, the Company is required to estimate its income taxes. Management judgment is required in determining the provision for the deferred tax asset.
The computation of the expense associated with stock-based compensation requires the use of a valuation model. ASC 718 is a complex accounting standard, the application of which requires significant judgment and the use of estimates, particularly surrounding Black-Scholes assumptions such as stock price volatility, expected option lives, and expected option forfeiture rates, to value equity-based compensation. The Company currently uses a Black-Scholes option pricing model to calculate the fair value of its stock options. The Company primarily uses historical data to determine the assumptions to be used in the Black-Scholes model and has no reason to believe that future data is likely to differ materially from historical data. However, changes in the assumptions to reflect future stock price volatility and future stock award exercise experience could result in a change in the assumptions used to value awards in the future and may result in a material change to the fair value calculation of stock-based awards. ASC 718 requires the recognition of the fair value of stock compensation in net income. Although every effort is made to ensure the accuracy of our estimates and assumptions, significant unanticipated changes in those estimates, interpretations and assumptions may result in recording stock option expense that may materially impact our financial statements for each respective reporting period.
IMPACT OF NEW ACCOUNTING PRONOUNCEMENTS
For information regarding new accounting pronouncements and their effect on the Company, see “New Accounting Pronouncements” in Note 2 of the unaudited notes to the condensed consolidated financial statements.
ITEM 3 - Quantitative and Qualitative Disclosures about Market Risk
The Company does not issue or invest in financial instruments or derivatives for trading or speculative purposes. Substantially all of the operations of the Company are conducted in the United States, and, as such, are not subject to material foreign currency exchange rate risk. All of our sales transactions are completed in US dollars.
Although the Company's assets included $1,627,000 in cash and $4,091,000 in marketable securities, the market rate risk associated with changing interest rates in the United States is not material.
ITEM 4 – Controls and Procedures
The Company has established and maintains “disclosure controls and procedures” (as those terms are defined in Rules 13a –15(e) and 15d-15(e) under the Securities and Exchange Act of 1934 (the “Exchange Act”). Christopher L. Coccio, Chief Executive Officer (principal executive) and Stephen J. Bagley, Chief Financial Officer (principal accounting officer) of the Company, have evaluated the Company’s disclosure controls and procedures as of November 30, 2018. Based on this evaluation, they have concluded that the Company’s disclosure controls and procedures were effective to ensure that information required to be disclosed by the Company in reports that it files or submits under the Exchange Act is (1) recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms, and (2) accumulated and communicated to Management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding timely disclosure.
In addition, there were no changes in the Company’s internal controls over financial reporting during the third fiscal quarter of 2019 that have materially affected, or are reasonably likely to materially affect, internal controls over financial reporting.
PART II - OTHER INFORMATION
|Item 1.||Legal Proceedings|
|Item 1A.||Risk Factors|
|Note Required for Smaller Reporting Companies|
|Item 2.||Unregistered Sales of Equity Securities and Use of Proceeds.|
|Item 3.||Defaults Upon Senior Securities|
|Item 4.||Mine Safety Disclosures|
|Item 5.||Other Information|
|Item 6.||Exhibits and Reports|
|31.1 – 31.2– Rule 13a - 14(a)/15d – 14(a) Certification|
|32.1 – 32.2 – Certification Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002.|
|101.INS – XBRL Instance Document.|
|101.SCH – XBRL Taxonomy Extension Schema Document|
|101.CAL – XBRL Taxonomy Calculation Linkbase Document|
|101.DEF – XBRL Taxonomy Extension Definition Linkbase Document|
|101.LAB – XBRL Extension Label Linkbase Document|
|101.PRE – XBRL Taxonomy Extension Presentation Linkbase Document|
In accordance with the requirements of the Exchange Act, the registrant has caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Dated: January 14, 2019
|By:||/s/ Christopher L. Coccio|
|Christopher L. Coccio|
|Chief Executive Officer|
|By:||/s/ Stephen J. Bagley|
|Stephen J. Bagley|
|Chief Financial Officer|